Document Detail


Laparoscopic versus open gastrectomy for gastric cancer: Long-term oncologic results.
MedLine Citation:
PMID:  24238126     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Data are lacking regarding the oncologic safety of laparoscopic gastrectomy (LG) for the treatment of gastric cancer. The aim of this study was to compare the long-term outcomes of LG with open gastrectomy (OG) for the treatment of gastric cancer.
METHODS: A total of 1,874 patients underwent curative distal or total gastrectomy for gastric adenocarcinoma between May 2003 and December 2009 and were included in this retrospective study. Recurrence-free survival and recurrence pattern were compared according to each tumor stage, and a subgroup analysis was performed in advanced gastric cancer patients who underwent D2 lymphadenectomy.
RESULTS: Of 1,874 patients, 816 were treated with OG and 1,058 with LG. No differences were observed in recurrence-free survival rates between the LG and the OG groups for any tumor stage. The number of harvested lymph nodes was similar between the two groups when analyzed according to tumor progression, operative procedure, and extent of lymphadenectomy. There were no differences between the 2 groups when we compared recurrence patterns after stratifying for tumor stage. The subgroup analysis in advanced gastric cancer patients who underwent D2 lymphadenectomy showed that there was no difference in the recurrence-free survival rates for any tumor stage between the 2 groups. Multivariate analysis indicated that the type of operative approach did not influence recurrence in either early or advanced gastric cancer patients.
CONCLUSION: LG for gastric cancer is an oncologically safe procedure with comparable long-term outcomes with OG.
Authors:
Ju-Hee Lee; Chang Min Lee; Sang-Yong Son; Sang Hoon Ahn; Do Joong Park; Hyung-Ho Kim
Related Documents :
17945036 - Oxaliplatin and fixed-rate infusional gemcitabine in the second-line treatment of patie...
16258436 - Evolving role of irinotecan in small-cell lung cancer.
17761976 - Nuclear factor-kb tumor expression predicts response and survival in irinotecan-refract...
15570076 - Randomized multicenter phase ii trial of bolus plus infusional fluorouracil/leucovorin ...
2135976 - Medulloblastomas.
23615696 - The european medicines agency review of pixantrone for the treatment of adult patients ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-11-12
Journal Detail:
Title:  Surgery     Volume:  -     ISSN:  1532-7361     ISO Abbreviation:  Surgery     Publication Date:  2013 Nov 
Date Detail:
Created Date:  2013-11-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0417347     Medline TA:  Surgery     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013 Mosby, Inc. All rights reserved.
Affiliation:
Department of Surgery, Seoul National University Bundang Hospital, Gyeonggi-do, South Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cytoskeleton-associated protein 2 is a potential predictive marker for risk of early and extensive r...
Next Document:  Renoprotective effect of sitagliptin against hypertensive nephropathy induced by chronic administrat...